KELLY THORNTON: Open Payments
NPI 1750492203 · BOONEVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 37 payments from 7 companies in 2025. Trend: 2023 $696 · 2024 $1,131 · 2025 $980
Food & beverage: $980
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $233 |
| ABBVIE INC. | 19 | $213 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $211 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
| Axsome Therapeutics, Inc. | 1 | $73 |
| PFIZER INC. | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, Kerendia, COBENFY, Wegovy, Auvelity, Ozempic, Rybelsus.
Industry payments across MS — which companies pay providers there.
